Anisdahl K, Lirhus SS, Medhus AW, Moum B, Melberg HO, Høivik ML (2024) Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study Dig Liver Dis (in press) DOI 10.1016/j.dld.2024.02.002, PubMed 38433021 Wiken TH, Høivik ML, Anisdahl K, Buer L, Warren DJ, Bolstad N, Hagen M, Moum BA, Medhus AW (2024) Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study Crohns Colitis 360, 6 (1), otae013 DOI 10.1093/crocol/otae013, PubMed 38544907
